<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00927771</url>
  </required_header>
  <id_info>
    <org_study_id>09-01-01</org_study_id>
    <nct_id>NCT00927771</nct_id>
  </id_info>
  <brief_title>Azelaic Acid Versus Hydroquinone in Melasma</brief_title>
  <official_title>Efficacy &amp; Safety of Azelaic Acid 15% Gel vs. Hydroquinone 4% Cream in the Treatment of Melasma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Callender Center for Clinical Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Callender Center for Clinical Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the safety and effectiveness of Azelaic Acid Gel to
      Hydroquinone Cream in the treatment of melasma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Melasma is a chronic condition in which dark areas appear on the forehead, cheeks, and upper
      lips. Hydroquinone is a skin lightener (or fade cream) and is one of the most commonly used
      medications for the treatment of melasma. Azelaic acid gel is currently used to treat acne
      and rosacea.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of melasma</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Melanosis</condition>
  <arm_group>
    <arm_group_label>Azelaic Acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroquinone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>azelaic acid gel</intervention_name>
    <description>azelaic acid 15% gel twice a day for 6 months</description>
    <arm_group_label>Azelaic Acid</arm_group_label>
    <other_name>Finacea Gel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hydroquinone cream</intervention_name>
    <description>hydroquinone 4% cream twice a day for 6 months</description>
    <arm_group_label>Hydroquinone</arm_group_label>
    <other_name>Claripel</other_name>
    <other_name>Lustra</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must have stable moderate-severe epidermal or mixed melasma involving the face

          -  all races

          -  males and females

          -  persons taking birth control medication, hormone replacement therapy or any other
             hormone altering medication may participate only if they have not started or stopped
             the medication within the last 3 months

        Exclusion Criteria:

          -  if the person has only dermal melasma

          -  pregnancy, breastfeeding, a positive pregnancy test in the office or plans to become
             pregnant

          -  a known allergy or sensitivity ot azelaic acid or hydroquinone

          -  the use of photosensitizing medications (ex. tetracycline) within 3 months of the
             study.

          -  starting or stopping hormonal medication within 3 months

          -  chemical peels, microdermabrasion, or laser treatment within 6 months

          -  worsening or improving melasma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valerie D Callender, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Howard University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tracy Brooks</last_name>
    <phone>301.249.0970</phone>
    <email>clinicalresearch@callenderskin.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cherie Young, MD</last_name>
    <phone>301.249.0970</phone>
    <email>clinicalresearch@callenderskin.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Callender Center for Clinical Research</name>
      <address>
        <city>Mitchellville</city>
        <state>Maryland</state>
        <zip>20721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Brooks</last_name>
      <phone>301-249-0970</phone>
      <email>clinicalresearch@callenderskin.com</email>
    </contact>
    <investigator>
      <last_name>Valerie D Callender, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cheshana Kindred, MD, MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cherie Young, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.callenderskin.com</url>
    <description>Home page to the Callender Skin &amp; Laser Center that includes the link &quot;Research Studies&quot; to the research page</description>
  </link>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2009</study_first_submitted>
  <study_first_submitted_qc>June 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2009</study_first_posted>
  <last_update_submitted>June 24, 2009</last_update_submitted>
  <last_update_submitted_qc>June 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Valerie D. Callender, MD</name_title>
    <organization>Callender Center for Clinical Research</organization>
  </responsible_party>
  <keyword>melanosis</keyword>
  <keyword>melasma</keyword>
  <keyword>azelaic acid</keyword>
  <keyword>hydroquinone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azelaic acid</mesh_term>
    <mesh_term>Hydroquinone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

